K2M Group Holdings Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
37,913.00
45,879.00
39,216.00
41,660.00
37,145.00
Depreciation, Depletion & Amortization
36,776.00
33,324.00
24,940.00
29,212.00
26,785.00
Other Funds
755.00
-
2,017.00
2,244.00
9,397.00
Funds from Operations
4,200.00
14,744.00
1,089.00
1,719.00
977.00
Changes in Working Capital
14,890.00
15,418.00
17,221.00
15,017.00
13,790.00
Net Operating Cash Flow
19,090.00
30,162.00
18,310.00
13,298.00
12,813.00
Capital Expenditures
9,934.00
15,871.00
14,280.00
31,021.00
17,944.00
Purchase/Sale of Investments
-
-
-
-
61.00
Net Investing Cash Flow
9,934.00
22,538.00
14,280.00
31,021.00
17,883.00
Cash Dividends Paid - Total
-
18,547.00
-
-
-
Issuance/Reduction of Debt, Net
16,384.00
48,078.00
-
46,889.00
973.00
Net Financing Cash Flow
29,380.00
56,836.00
56,226.00
49,133.00
8,424.00
Net Change in Cash
408.00
3,992.00
23,235.00
4,257.00
21,547.00
Free Cash Flow
20,584.00
45,915.00
32,002.00
43,012.00
27,799.00
Deferred Taxes & Investment Tax Credit
8,492.00
218.00
-
33.00
1,657.00
Change in Capital Stock
13,751.00
123,461.00
54,209.00
-
-
Exchange Rate Effect
52.00
144.00
401.00
557.00
725.00
Other Uses
-
6,667.00
-
-
-

About K2M Group Holdings

View Profile
Address
600 Hope Parkway SE
Leesburg Virginia 20175
United States
Employees -
Website http://www.k2m.com
Updated 09/14/2018
K2M Group Holdings, Inc. is a global medical device company. It focused on designing, developing and commercializing innovative and proprietary complex spine technologies and techniques. The company's complex spine products are used by spine surgeons to treat some of the most difficult and challenging spinal pathologies, such as deformity, trauma and tumor.